Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more
Market Cap & Net Worth: Monogram Orthopaedics Inc. Common Stock (MGRM)
Monogram Orthopaedics Inc. Common Stock (NASDAQ:MGRM) has a market capitalization of $243.79 Million ($243.79 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15471 globally and #6076 in its home market, demonstrating a 1.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Monogram Orthopaedics Inc. Common Stock's stock price $6.00 by its total outstanding shares 40632367 (40.63 Million).
Monogram Orthopaedics Inc. Common Stock Market Cap History: 2023 to 2025
Monogram Orthopaedics Inc. Common Stock's market capitalization history from 2023 to 2025. Data shows change from $139.78 Million to $243.79 Million (-24.52% CAGR).
Index Memberships
Monogram Orthopaedics Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #414 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1466 of 3165 |
Weight: Monogram Orthopaedics Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Monogram Orthopaedics Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Monogram Orthopaedics Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
382.95x
Monogram Orthopaedics Inc. Common Stock's market cap is 382.95 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $139.78 Million | $365.00K | -$13.75 Million | 382.95x | N/A |
Competitor Companies of MGRM by Market Capitalization
Companies near Monogram Orthopaedics Inc. Common Stock in the global market cap rankings as of March 19, 2026.
Key companies related to Monogram Orthopaedics Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Monogram Orthopaedics Inc. Common Stock Historical Marketcap From 2023 to 2025
Between 2023 and today, Monogram Orthopaedics Inc. Common Stock's market cap moved from $139.78 Million to $ 243.79 Million, with a yearly change of -24.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $243.79 Million | +153.16% |
| 2024 | $96.30 Million | -31.10% |
| 2023 | $139.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Monogram Orthopaedics Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $243.79 Million USD |
| MoneyControl | $243.79 Million USD |
| MarketWatch | $243.79 Million USD |
| marketcap.company | $243.79 Million USD |
| Reuters | $243.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.